Tumor gene expression patterns affecting response to BCl-2 inhibitor venetoclax in acute myeloid leukemia

被引：0
|
作者：
Garay, Juan Antonio Raygoza
Yun, Seongseok
Osman, Afaf
Ramlal, Reshma
Feith, David
Churchman, Michelle
Dhakal, Prajwal
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5852
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5852
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    M Kontro
    A Kumar
    M M Majumder
    S Eldfors
    A Parsons
    T Pemovska
    J Saarela
    B Yadav
    D Malani
    Y Fløisand
    M Höglund
    K Remes
    B T Gjertsen
    O Kallioniemi
    K Wennerberg
    C A Heckman
    K Porkka
    Leukemia, 2017, 31 : 301 - 309
  • [2] HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
    Kontro, M.
    Kumar, A.
    Majumder, M. M.
    Eldfors, S.
    Parsons, A.
    Pemovska, T.
    Saarela, J.
    Yadav, B.
    Malani, D.
    Floisand, Y.
    Hoglund, M.
    Remes, K.
    Gjertsen, B. T.
    Kallioniemi, O.
    Wennerberg, K.
    Heckman, C. A.
    Porkka, K.
    LEUKEMIA, 2017, 31 (02) : 301 - 309
  • [3] Effect and Mechanism of NL-101 Combined with Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia
    Jiang, Xia
    Zhuang, Haihui
    Li, Fenglin
    Jiang, Lei
    Jin, Jie
    Lu, Ying
    BLOOD, 2023, 142
  • [4] COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX
    Waclawiczek, A.
    Leppa, A.
    Renders, S.
    Stumpf, K.
    Reyneri, C.
    Betz, B.
    Janssen, M.
    Shahswar, R.
    Donato, E.
    Unglaub, J. M.
    Schlenk, R. F.
    Hundemer, M.
    Pabst, C.
    Heuser, M.
    Raffel, S.
    Mueller-Tidow, C.
    Sauer, T. .
    Trumpp, A.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S45 - S45
  • [5] BCL-2 ONCOPROTEIN EXPRESSION IN ACUTE MYELOID-LEUKEMIA
    BENSI, L
    LONGO, R
    VECCHI, A
    MESSORA, C
    GARAGNANI, L
    BERNARDI, S
    TAMASSIA, MG
    SACCHI, S
    HAEMATOLOGICA, 1995, 80 (02) : 98 - 102
  • [6] AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia
    Legrand, Noemie
    Pradier, Amandine
    Poulain, Laury
    Mouche, Sarah
    Birsen, Rudy
    Larrue, Clement
    Simonetta, Federico
    Tamburini, Jerome
    CANCERS, 2021, 13 (23)
  • [7] A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML)
    Ando, Hidenori
    Murakami, Yuta
    Eshima, Kiyoshi
    Ishida, Tatsuhiro
    CANCER REPORTS, 2022, 5 (03)
  • [8] Strategies for the prophylaxis of invasive fungal diseases in acute myeloid leukemia patients undergoing Bcl-2 inhibitor venetoclax treatment
    Li, Pengfei
    Luo, Zhiming
    Deng, Jianchuan
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (02)
  • [9] Telomerase inhibitor imetelstat in combination with the BCL-2 inhibitor venetoclax enhances apoptosis in vitro and increases survival in vivo in acute myeloid leukemia
    Rusbuldt, Joshua J.
    Luistro, Leopoldo
    Chin, Diana
    Smith, Melissa
    Wong, Amy
    Romero, Margarita
    Rizo, Aleksandra
    Bussolari, Jacqueline
    Huang, Fei
    Sasser, Amy
    CANCER RESEARCH, 2017, 77
  • [10] A STUDY OF THE EXPRESSION OF BCL-2 GENE-EXPRESSION IN 19 PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    ANDERSON, RJ
    PRENTICE, HG
    MACDONALD, ID
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1100 - 1100
12345